Craig Ulrick
Chief Tech/Sci/R&D Officer chez TELIX PHARMACEUTICALS LIMITED
Profil
Craig Ulrick is currently the Chief Information Officer at Telix Pharmaceuticals Ltd.
Prior to this, he was the Chief Information Officer at Acumentis Group Ltd.
from 2018 to 2022 and the Global Head-Technology at Sirtex Medical Pty Ltd.
from 2017 to 2018.
Ulrick obtained an undergraduate degree from Australian Catholic University.
Postes actifs de Craig Ulrick
| Sociétés | Poste | Début |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Craig Ulrick
| Sociétés | Poste | Fin |
|---|---|---|
| ACUMENTIS GROUP LIMITED | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| SIRTEX MEDICAL LIMITED | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Formation de Craig Ulrick
| Australian Catholic University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACUMENTIS GROUP LIMITED | Finance |
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sirtex Medical Pty Ltd.
 Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Sirtex Medical Ltd. manufactures, and distributes liver cancer treatments. It operates through the following geographical segments: Asia Pacific, Americas, and Europe, Middle East, and Africa. It offers targeted radiation therapy known as SIR Spheres Y-90 resin microspheres. The company was founded in 1997 and is headquartered in St Leonards, Australia. | Commercial Services |
